Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/f2e62926-19ff-49c0-a8a3-044eb7a53390/

SIG

Sigma Healthcare Limited
Chart
2.84 AUD
Latest Week 2026-07-24
Snapshot 2026-07-26 · 0.7w · Fresh
0.15
OS Score
3.0%
Value
83.0%
Quality
17.0%
Momentum
4/9
F-Score
0.158
QV
Strategy Eligibility
0 of 23 passing
OS Composite
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
3.0%ile
P/E
61.9×
P/S
5.5×
E/P
0.0203
FCF Yield
0.016
EBITDA/EV
0.025
SH Yield
0.012
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
97.00000000
/100 — 1=cheapest
VC2 (Trending Value)
95.00000000
/100
VC3 (Buyback)
95.00000000
/100
P/E of 61.9x is premium-priced — the market is paying up for expected growth. VC2 score of 95.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
83.0%ile
ROE
-373.705
ROA
0.289
Net Margin
0.088
Op Margin
0.111
GPA
0.787
Current
1.59
F-Score
4/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.237
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
17.0%ile
6M Return
-6.5%
12M Return
1.2%
12-1 Mom
-1.3%
Risk-Adj
-0.06
Vol 252d
22.9%
Vol 60d
52.1%
↑ Expanding
Max DD 12M
-15.7%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (52%) is expanding vs long-term (23%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.15
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 145 peers
Sector Value %ile
8.2%
Sector Quality %ile
88.4%
P/E z-score
-0.02
Sector Avg OS
43.2%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
VLS Vita Life Sciences Limited 98.0% 93.0% 97.0% 89.0%
SDI SDI Limited 96.0% 86.0% 88.0% 96.0%
BP8 BPH Global Ltd 93.0% 81.0% 80.0% 81.0%
AGN Argenica Therapeutics Limited 93.0% 82.0% 80.0% 81.0%
PCK PainChek Limited 89.0% 78.0% 76.0% 77.0%
TRI TrivarX Limited 87.0% 76.0% 75.0% 76.0%
AVH AVITA Medical, Inc. 85.0% 75.0% 73.0% 74.0%
ACL Australian Clinical Labs Limited 85.0% 94.0% 98.0% 12.0%
Factor Interactions
Quality at a Premium
High quality (83th) but expensive (3th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (52%) significantly exceeds 252-day (23%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
23.5% avg (6 factors)
Quality
C
56.0% avg (6 factors)
Momentum
F
29.8% avg (4 factors)
Risk
A
78.5% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.150—1
Value %ile0.030—8
Quality %ile0.830—8
Momentum %ile0.170—1
F-Score4.000—8
Confidence0.403—0
Volatility0.229—0
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
61.87
Earnings Yield (E/P)
0.0203
Price / Sales
5.46
FCF Yield
1.6%
EBITDA / EV
2.5%
Sales Yield (1/P·S)
0.1824
Shareholder Yield
Div + net buyback / mktcap
1.2%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-37370.5%
Return on Assets
28.9%
Net Margin
8.8%
Operating Margin
11.1%
Gross Profit / Assets
Novy-Marx GPA
78.7%
Current Ratio
1.59
External Financing
Net issuance — lower=better
0.007
MomentumPrice trend strength over different horizons
6M Return
-6.5%
12M Return
1.2%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-1.3%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.06
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
23.7%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
4
Dividend Yield
1.2%
Buyback Yield
-0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
97
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
95
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
95
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity